These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 15180612)
1. Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome. Campbell PA; Conrad RJ; Campbell CM; Nicol DL; MacTaggart P BJU Int; 2004 Jun; 93(9):1228-31. PubMed ID: 15180612 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology. Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341 [TBL] [Abstract][Full Text] [Related]
3. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results. Curry JL; Wojcik EM Cancer; 2002 Jun; 96(3):140-5. PubMed ID: 12115301 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases. Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527 [TBL] [Abstract][Full Text] [Related]
5. Urothelial neoplasia of the urinary bladder--comparison of interobserver variability for WHO Classification 1972 with WHO/ISUP Consensus Classification 1998. Mamoon N; Iqbal MA; Jamal S; Luqman M J Ayub Med Coll Abbottabad; 2006; 18(2):4-8. PubMed ID: 16977804 [TBL] [Abstract][Full Text] [Related]
6. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up. Yin H; Leong AS Am J Clin Pathol; 2004 May; 121(5):679-87. PubMed ID: 15151208 [TBL] [Abstract][Full Text] [Related]
7. Comparison of 1998 WHO/ISUP and 1973 WHO classifications for interobserver variability in grading of papillary urothelial neoplasms of the bladder. Pathological evaluation of 258 cases. Gonul II; Poyraz A; Unsal C; Acar C; Alkibay T Urol Int; 2007; 78(4):338-44. PubMed ID: 17495493 [TBL] [Abstract][Full Text] [Related]
8. Non-invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system. Miyamoto H; Miller JS; Fajardo DA; Lee TK; Netto GJ; Epstein JI Pathol Int; 2010 Jan; 60(1):1-8. PubMed ID: 20055945 [TBL] [Abstract][Full Text] [Related]
9. Papillary urothelial neoplasm of low malignant potential: evolving terminology and concepts. Jones TD; Cheng L J Urol; 2006 Jun; 175(6):1995-2003. PubMed ID: 16697785 [TBL] [Abstract][Full Text] [Related]
10. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification. Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI J Urol; 2005 Nov; 174(5):1976-80. PubMed ID: 16217372 [TBL] [Abstract][Full Text] [Related]
11. [New WHO classification of urothelial carcinoma of the urinary bladder]. Helpap B Verh Dtsch Ges Pathol; 2002; 86():57-66. PubMed ID: 12647352 [TBL] [Abstract][Full Text] [Related]
12. Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification. Whisnant RE; Bastacky SI; Ohori NP Diagn Cytopathol; 2003 Apr; 28(4):186-90. PubMed ID: 12672093 [TBL] [Abstract][Full Text] [Related]
14. P53 overexpression in bladder urothelial neoplasms: new aspect of World Health Organization/International Society of Urological Pathology classification. Kalantari MR; Ahmadnia H Urol J; 2007; 4(4):230-3. PubMed ID: 18270948 [TBL] [Abstract][Full Text] [Related]
15. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder. Pich A; Chiusa L; Formiconi A; Galliano D; Bortolin P; Comino A; Navone R Cancer; 2002 Aug; 95(4):784-90. PubMed ID: 12209722 [TBL] [Abstract][Full Text] [Related]
16. Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system. Holmäng S; Johansson SL Urology; 2005 Aug; 66(2):274-8. PubMed ID: 16098355 [TBL] [Abstract][Full Text] [Related]
17. Frequent FGFR3 mutations in urothelial papilloma. van Rhijn BW; Montironi R; Zwarthoff EC; Jöbsis AC; van der Kwast TH J Pathol; 2002 Oct; 198(2):245-51. PubMed ID: 12237885 [TBL] [Abstract][Full Text] [Related]
18. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder. Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286 [TBL] [Abstract][Full Text] [Related]
20. High-grade papillary urothelial carcinoma of the urinary tract: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center. Chaux A; Karram S; Miller JS; Fajardo DA; Lee TK; Miyamoto H; Netto GJ Hum Pathol; 2012 Jan; 43(1):115-20. PubMed ID: 21820145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]